<DOC>
	<DOCNO>NCT02479308</DOCNO>
	<brief_summary>This study evaluate effect ALKS 5461 QT interval healthy volunteer well evaluate safety tolerability ALKS 5461 .</brief_summary>
	<brief_title>A Study Evaluate Effect ALKS 5461 QT Intervals Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<criteria>Have body mass index ( BMI ) 18.030.0 kg/m2 screening Is physically healthy Agree abide contraception requirement duration study Additional criterion may apply Have positive pregnancy test and/or currently breastfeed Have history current infection Hepatitis B virus , Hepatitis C virus , human immunodeficiency virus ( HIV ) Have current evidence history clinically significant medical psychiatric condition observe abnormality Have skin condition likely interfere ECG electrode placement adhesion Have current abuse dependence ( within past 5 year ) drug ( exclusive nicotine caffeine ) Have use prescription overthecounter ( OTC ) medication , include natural health product dietary supplement ( exception prescription contraceptives hormonal replacement , acetaminophen , ibuprofen , multivitamin ) , consume grapefruit grapefruit product within 14 day prior first study drug dose Have consume alcohol , caffeine , xanthinecontaining product within 24 hour prior first study drug dose Have use nicotine within 90 day prior first study drug dose Have use opioids 30 day prior screen , anticipated need opioid medication study Additional criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Alkermes</keyword>
	<keyword>Samidorphan</keyword>
	<keyword>ALKS 5461</keyword>
	<keyword>QT/QTc</keyword>
	<keyword>Buprenorphine</keyword>
	<keyword>Pharmacodynamics</keyword>
</DOC>